This study is testing an experimental oral drug called TVB-2640 in people with advanced non-small cell lung cancer that has a specific genetic change called a KRAS mutation and has stopped responding to standard treatments. The main goals are to see if the drug can control the ca…
Phase: PHASE2 • Sponsor: David E Gerber • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC